Rajesh Sumanlal Shah

Rajesh Sumanlal Shah

Active Director Director DIN 00821466
DIN 00821466 First appointment Aug 1987 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Aug 1987
Shareholding value •••• Premium profile

About Rajesh Sumanlal Shah

Data last updated:

Rajesh Sumanlal Shah is a Director at Mepro Pharmaceuticals Private Limited (since 1987), Whole-Time Director at Mepromax Life Sciences Private Limited (since 2006) and Director at Sunshine Organics Pvt Ltd (since 1988), and holds 1 more current directorship. The companies operate in Pharma and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹463 Cr; the largest is Mepro Pharmaceuticals Private Limited at ₹356 Cr (FY 2025). Earlier, Rajesh Sumanlal Shah was a Director at Midland Pharmaceuticals Private Limited (from 1987).

DIN 00821466
Primary Designation Director
Industry Pharma
First Appointment 17 Aug 1987
Oldest Company Age 44 yrs
Largest company Mepro Pharmaceuticals Private Limited · ₹356 Cr (FY 2025)
Combined revenue ₹463 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 19871982₹356 Cr (FY 2025)Active
Whole-Time Director15 Jun 20062005₹82.29 Cr (FY 2025)Active
Sunshine Organics Pvt Ltd U24110MH1988PTC048981
Director15 Nov 19881988₹23.76 Cr (FY 2025)Active
Designated Partner15 Jul 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 19871987Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sunshine Organics Pvt Ltd
Mepro Pharmaceuticals Private Limited
Midland Pharmaceuticals Private Limited
Mepromax Life Sciences Private Limited
Premium access

Shareholding and investment profile for Rajesh Sumanlal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Sumanlal Shah

Rajesh Sumanlal Shah currently holds 4 directorships: Mepro Pharmaceuticals Private Limited (Director, since 30 Sep 1987, revenue ₹356 Cr (FY 2025)); Mepromax Life Sciences Private Limited (Whole-Time Director, since 15 Jun 2006, revenue ₹82.29 Cr (FY 2025)); Sunshine Organics Pvt Ltd (Director, since 15 Nov 1988, revenue ₹23.76 Cr (FY 2025)); Rushraj Enterprises Llp (Designated Partner, since 15 Jul 2026).

Rajesh Sumanlal Shah was first appointed on 17 Aug 1987 as Director at Midland Pharmaceuticals Private Limited. The most recent appointment on record is 15 Jul 2026 at Rushraj Enterprises Llp.

The 3 current companies of Rajesh Sumanlal Shah that report revenue have a combined latest revenue of ₹463 Cr: Mepro Pharmaceuticals Private Limited ₹356 Cr (FY 2025); Mepromax Life Sciences Private Limited ₹82.29 Cr (FY 2025); Sunshine Organics Pvt Ltd ₹23.76 Cr (FY 2025).

Rajesh Sumanlal Shah held 1 earlier board appointment: Midland Pharmaceuticals Private Limited (Director, from 17 Aug 1987).

The current boards of Rajesh Sumanlal Shah's companies include Bharatkumar Chabildas Shah (Mepro Pharmaceuticals Private Limited), Prakash Navinchandra Shah (Mepro Pharmaceuticals Private Limited), Suresh Chhabildas Shah (Mepro Pharmaceuticals Private Limited), Vijay Chhabildas Shah (Mepro Pharmaceuticals Private Limited), Amritlal Bhabutmal Solanki (Sunshine Organics Pvt Ltd), Kamleshkumar Amritlal Solanki (Sunshine Organics Pvt Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available